Pulse versus oral cyclophosphamide in the treatment of Wegener's granulomatosis: comment on the article by Guillevin et al.
Langford
C A
CA
Sneller
M C
MC
D000284:Administration, Oral; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D003520:Cyclophosphamide / Q000008:administration & dosage*; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy*; D006801:Humans; D007275:Injections, Intravenous; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D016896:Treatment Outcome
D018501:Antirheumatic Agents; D003520:Cyclophosphamide